Recruiting

Molecular Profiling

Sponsor:

Montefiore Medical Center

Code:

NCT00200486

Conditions

Head and Neck Neoplasms

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to study the genetic profile of head and neck tumors and their relationship to treatment response and outcome

Conditions

Head and Neck Neoplasms

Study ID

NCT00200486

Start date

Oct 1, 2002

Status verified date

Apr, 2026

Completion date

Dec, 2030

Anticipated

Primary completion date

Dec, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • actual or suspected malignant or non-malignant tumors of the head and neck
  • planned biopsy and/or resection, or availability of paraffin embedded or stored frozen tumor tissue for non-genetic analysis

Exclusion Criteria:

  • insufficient tissue available for both standard diagnostic evaluation and study specimen

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • correlation of treatment response and prognosis (time to recurrence and survival) with genetic expression profile [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Stelby Augustine, RN

718-920-7054staugust@montefiore.org

Richard V Smith, MD

718-920-2991rsmith@montefiore.org

Locations

Stelby Augustine

Recruiting

The Bronx, New York, United States, 10467

Contacts

Stelby Augustine, RN

718-920-7054staugust@montefiore.org

Richard V Smith, MD

718-920-2991rsmith@montefore.org

Principal Investigator:

Richard V Smith, MD

More Information

Sponsor

Montefiore Medical Center

Last update posted

Apr 9, 2026

Last verified

Apr, 2026

Keywords

  • genetic microarray
  • head and neck cancer

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Montefiore Medical Center on 2026-04-09.